ABVC BioPharma Inc.

ABVC | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.14

-$0.01 (-0.87%)

Sep 22, 2026, 2:42 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.87%

(1D)

Rating

Updated: Aug 22, 2026

39.5

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $29.64M

1D Range

1.13 1.20

52W Range

0.71 3.40

Valuation (TTM)

PE -3.97

PB 2.91

EV/EBITDA -4.03

Valuation (NTM)

Forward PE 1.65

Forward PEG 0.03

Price Target N/A

Cash Flow

FCF Yield -8.2%

SBC Adj. FCF Yield -19.3%

SBC Impact -135.3%

Margins

Gross Margin 100.0%

Operating Margin 918.5%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -521.2% | -154.2%

Dil EPS 3Y | 5Y 95.3% | 64.0%

FCF 3Y | 5Y 11.1% | 42.2%

Returns

ROA -40.7%

ROE -71.5%

ROIC -52.0%

Financial Health

Net Cash

$94.36K

Current Ratio 0.07

Interest Coverage -47.11

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States...

Sector Healthcare

Industry Biotechnology

Employees 18

IPO Date Nov 9, 2004

Website www.abvcpharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 16, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞